-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Candel Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2020 to 2023.
- Candel Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $1.84M, a 151% increase year-over-year.
- Candel Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $4.51M, a 58.6% increase year-over-year.
- Candel Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $3.09M, a 34% increase from 2022.
- Candel Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $2.31M, a 22.1% decline from 2021.
- Candel Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $2.96M, a 40.6% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)